Terms: = Breast cancer AND HOXD13, SPD, 3239, P35453, HOX4I AND Prognosis
13 results:
1. spd-L1 and spd-L2 in plasma of patients with lung cancer and their clinical significance.
Han S; Zhang Y; Yuan J; Wu Y; Zhou Y; Zhou Y; Li X; Zhou S
Cytokine; 2024 Apr; 176():156532. PubMed ID: 38330638
[TBL] [Abstract] [Full Text] [Related]
2. Hyperthermic intrathoracic extracorporeal chemotherapy for secondary malignant pleural disease.
Miller DL; Parks CS; Ange B; Bonta IR; Rich PT
J Surg Oncol; 2023 Sep; 128(4):604-611. PubMed ID: 37409778
[TBL] [Abstract] [Full Text] [Related]
3. The clinical implication of soluble PD-L1 (spd-L1) in patients with breast cancer and its biological function in regulating the function of T lymphocyte.
Han B; Dong L; Zhou J; Yang Y; Guo J; Xuan Q; Gao K; Xu Z; Lei W; Wang J; Zhang Q
Cancer Immunol Immunother; 2021 Oct; 70(10):2893-2909. PubMed ID: 33688997
[TBL] [Abstract] [Full Text] [Related]
4. Serum spd-1 and spd-L1 as Biomarkers for Evaluating the Efficacy of Neoadjuvant Chemotherapy in Triple-Negative breast cancer Patients.
Li Y; Cui X; Yang YJ; Chen QQ; Zhong L; Zhang T; Cai RL; Miao JY; Yu SC; Zhang F
Clin Breast Cancer; 2019 Oct; 19(5):326-332.e1. PubMed ID: 31176611
[TBL] [Abstract] [Full Text] [Related]
5. Sparse Representation Over Learned Dictionaries on the Riemannian Manifold for Automated Grading of Nuclear Pleomorphism in breast cancer.
Das A; Nair MS; Peter SD
IEEE Trans Image Process; 2019 Mar; 28(3):1248-1260. PubMed ID: 30346284
[TBL] [Abstract] [Full Text] [Related]
6. Pathological Significance and Prognostic Value of Surfactant Protein D in cancer.
Mangogna A; Belmonte B; Agostinis C; Ricci G; Gulino A; Ferrara I; Zanconati F; Tripodo C; Romano F; Kishore U; Bulla R
Front Immunol; 2018; 9():1748. PubMed ID: 30127783
[TBL] [Abstract] [Full Text] [Related]
7. Physical activity for women with breast cancer after adjuvant therapy.
Lahart IM; Metsios GS; Nevill AM; Carmichael AR
Cochrane Database Syst Rev; 2018 Jan; 1(1):CD011292. PubMed ID: 29376559
[TBL] [Abstract] [Full Text] [Related]
8. Programmed death-ligand 1 and its soluble form are highly expressed in nasal natural killer/T-cell lymphoma: a potential rationale for immunotherapy.
Nagato T; Ohkuri T; Ohara K; Hirata Y; Kishibe K; Komabayashi Y; Ueda S; Takahara M; Kumai T; Ishibashi K; Kosaka A; Aoki N; Oikawa K; Uno Y; Akiyama N; Sado M; Takei H; Celis E; Harabuchi Y; Kobayashi H
Cancer Immunol Immunother; 2017 Jul; 66(7):877-890. PubMed ID: 28349165
[TBL] [Abstract] [Full Text] [Related]
9. Circulating long noncoding RNA GAS5 as a potential biomarker in breast cancer for assessing the surgical effects.
Han L; Ma P; Liu SM; Zhou X
Tumour Biol; 2016 May; 37(5):6847-54. PubMed ID: 26662314
[TBL] [Abstract] [Full Text] [Related]
10. Prognostic significance of hoxd13 expression in human breast cancer.
Zhong ZB; Shan M; Qian C; Liu T; Shi QY; Wang J; Liu Y; Liu Y; Huang YX; Pang D
Int J Clin Exp Pathol; 2015; 8(9):11407-13. PubMed ID: 26617867
[TBL] [Abstract] [Full Text] [Related]
11. hoxd13 methylation status is a prognostic indicator in breast cancer.
Zhong Z; Shan M; Wang J; Liu T; Xia B; Niu M; Ren Y; Pang D
Int J Clin Exp Pathol; 2015; 8(9):10716-24. PubMed ID: 26617782
[TBL] [Abstract] [Full Text] [Related]
12. HOX D13 expression across 79 tumor tissue types.
Cantile M; Franco R; Tschan A; Baumhoer D; Zlobec I; Schiavo G; Forte I; Bihl M; Liguori G; Botti G; Tornillo L; Karamitopoulou-Diamantis E; Terracciano L; Cillo C
Int J Cancer; 2009 Oct; 125(7):1532-41. PubMed ID: 19488988
[TBL] [Abstract] [Full Text] [Related]
13. Eigengene-based linear discriminant model for tumor classification using gene expression microarray data.
Shen R; Ghosh D; Chinnaiyan A; Meng Z
Bioinformatics; 2006 Nov; 22(21):2635-42. PubMed ID: 16926220
[TBL] [Abstract] [Full Text] [Related]
